NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia.
- DOI
- 10.1016/j.pnpbp.2025.111569
- Published
- 2025 Dec 20
- Container
- Progress in neuro-psychopharmacology & biological psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pnpbp.2025.111569,
title = {NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia.},
author = {Fedorenko OY and Poltavskaya EG and Kornetova EG and Freidin MB and Bocharova AV and Boiko AS and Stepanov VA and Bokhan NA and Ivanova SA and Strelnikov K},
year = {2025},
journal = {Progress in neuro-psychopharmacology \& biological psychiatry},
doi = {10.1016/j.pnpbp.2025.111569},
url = {https://doi.org/10.1016/j.pnpbp.2025.111569}
}RIS
TY - JOUR TI - NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia. AU - Fedorenko OY AU - Poltavskaya EG AU - Kornetova EG AU - Freidin MB AU - Bocharova AV AU - Boiko AS AU - Stepanov VA AU - Bokhan NA AU - Ivanova SA AU - Strelnikov K PY - 2025 JO - Progress in neuro-psychopharmacology & biological psychiatry DO - 10.1016/j.pnpbp.2025.111569 UR - https://doi.org/10.1016/j.pnpbp.2025.111569 ER -
APA
OY, F., EG, P., EG, K., MB, F., AV, B., AS, B., VA, S., NA, B., SA, I., & K, S. (2025). NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia.. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2025.111569
Source records
- pubmed · retrieved 2026-09-25T22:24:17.088Z